Navina Secures $55M to Expand AI-Powered Clinical Intelligence

What You Should Know: 

– Navina, a provider of AI-powered clinical intelligence raises $55M in Series C funding round, bringing its total funding to $100M. 

– The investment, led by Growth Equity at Goldman Sachs Alternatives, with participation from existing investors including Vertex Ventures Israel, Grove Ventures, and ALIVE, will fuel Navina’s expansion across the U.S. healthcare market and drive further innovation in its AI technology.

AI-Powered Copilot Delivering Clinical Intelligence

The healthcare industry’s ongoing transition toward value-based care has underscored the need for accurate and timely clinical intelligence. However, fragmented data, inefficient manual workflows, and increasing administrative burdens present significant challenges to clinicians seeking to deliver proactive, preventive patient care. These obstacles often lead to poor clinical outcomes and higher healthcare costs.

Navina addresses these challenges by equipping clinicians and care teams with real-time, data-driven insights that improve both care quality and financial outcomes. The AI copilot surfaces critical clinical information to support effective decision-making throughout the care continuum, from back-office operations to point-of-care interventions, while significantly reducing administrative burdens. Navina’s seamless integration into clinician workflows and its impressive 86% weekly active usage rate demonstrate the high level of trust clinicians place in its AI recommendations.

Expansion Plans & Recent Milestones

Navina has established strategic partnerships with industry leaders such as agilon health, InnovaCare Health, Millennium Physician Group, and Privia Health. The company’s recent recognition as Best in KLAS 2025 for Clinician Digital Workflow further validates its commitment to customer satisfaction and trust.

The Series C funding will enable Navina to enhance its AI copilot, a solution designed to improve patient outcomes by delivering proactive clinical intelligence at every outpatient interaction. Navina’s platform has quickly become a trusted resource for value-based care organizations, starting with primary care and expanding to broader healthcare segments. To date, the platform supports over 10,000 healthcare professionals across 1,300 clinics, facilitating care for more than three million patients.

“This investment is a powerful validation of Navina’s vision to improve patient outcomes and healthcare economics by breaking down data barriers with AI,” said Ronen Lavi, co-founder and CEO of Navina. “We’re thrilled to partner with a best-in-class firm like Goldman Sachs, whose market leadership will be instrumental as we enter this pivotal growth phase and expand our market reach. With this additional capital, we will continue to accelerate AI innovation and revolutionize healthcare by making every patient interaction more empathic, personalized, and proactive.”